Sala de prensa


Bioventus Expands to Mexico with DUROLANE for Knee OA Patients

Bioventus Expands to Mexico with DUROLANE® for Knee Osteoarthritis Patients HOOFDDORP, THE NETHERLANDS – November 14, 2016 – Bioventus, a leader in…

Read More

Bioventus Appoints Andrew McCartney Managing Director, International for EMEA

Bioventus Appoints Andrew McCartney Managing Director, International for EMEA DURHAM, NC – November 7, 2016 – Bioventus, a global leader in…

Read More

Bioventus Launches EXOGEN in the Kingdom of Saudi Arabia

Bioventus Launches EXOGEN® Ultrasound Bone Healing System in the Kingdom of Saudi Arabia HOOFDDORP, THE NETHERLANDS – September 19, 2016 – Bioventus,…

Read More

Fractures That Fail to Heal May Be Predictable

Fractures That Fail to Heal May Be Predictable Based on Patient Risk Factors DURHAM, NC – September 8, 2016 – Recent research has shed light on the…

Read More

Bioventus Launches GELSYN-3™ for Treatment of Knee Osteoarthritis Pain

Bioventus Launches GELSYN-3™ for Treatment of Knee Osteoarthritis Pain DURHAM, NC – August 9, 2016 – Bioventus, a global leader in orthobiologic…

Read More

Bioventus Extends Distribution Agreement for SUPARTZ FX

Bioventus Extends Distribution Agreement for SUPARTZ FX™ DURHAM, NC – July 1, 2016 – Bioventus, a global leader in orthobiologic solutions, today…

Read More

Michael Minogue Named to Bioventus Board of Managers

Michael Minogue Named to Bioventus Board of Managers DURHAM, NC – June 24, 2016 – Bioventus, a global leader in orthobiologic solutions, today…

Read More

Olympic and Norwegian World Cup Medal Winning Skier Magnus Moan to Appear at NOF 2016

Olympic and Norwegian World Cup Medal Winning Skier Magnus Moan to Appear at Nordic Orthopaedic Federation Congress Will Share Fracture Healing…

Read More

Bioventus Introduces New Products at AAOS

Bioventus Introduces New Products for Spine Surgery, Osteoarthritis at AAOS ORLANDO – March 2, 2016 – Bioventus, a leader in orthobiologic solutions,…

Read More

Bioventus Enters Into Agreement with IBSA for Rights to GELSYN-3

Bioventus Enters Into Agreement with IBSA for Rights to GELSYN-3™ DURHAM, NC – February 23, 2016 – Bioventus, a global leader in orthobiologic…

Read More

Buscar noticias


Consultas de prensa


Thomas Hill
Director de Comunicaciones Corporativas
919.474.6715
[email protected]

Descargar biblioteca


Logotipos corporativos y de marca
Descargar ahora

Imágenes de productos
Descargar ahora